Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19

BACKGROUND: Patients with COVID-19 have a higher risk of thrombosis and thromboembolism, but the underlying mechanism(s) remain to be fully elucidated. In patients with COVID-19, high lipoprotein(a) (Lp(a)) is positively associated with the risk of ischemic heart disease. Lp(a), composed of an apoB-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ziyu, Dai, Wen, Zhu, Wen, Rodriguez, Maya, Lund, Hayley, Xia, Yuhe, Chen, Yiliang, Rau, Mary, Schneider, Ellen Anje, Graham, Mary Beth, Jobe, Shawn, Wang, Demin, Cui, Weiguo, Wen, Renren, Whiteheart, Sidney W., Wood, Jeremy P., Silverstein, Roy, Berger, Jeffery S., Kreuziger, Lisa Baumann, Barrett, Tessa J., Zheng, Ze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480648/
https://www.ncbi.nlm.nih.gov/pubmed/37680312
http://dx.doi.org/10.1016/j.rpth.2023.102164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480648/
https://www.ncbi.nlm.nih.gov/pubmed/37680312
http://dx.doi.org/10.1016/j.rpth.2023.102164

Ejemplares similares